Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. AQST
  6. >
  7. Forecast
stocks logo

AQST Stock Price Prediction

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

Should I Buy Aquestive Therapeutics Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AQST has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

AQST stock price ended at $2.38 on Friday, after rising 0%

The Aquestive Therapeutics Inc stock price increased by 0% on the last trading day (16 May 2025), rising from 2.38 to 2.38. Throughout the last trading session, the stock experienced a fluctuation of 5.77% , ranging from a day low of $2.34 to a day high of 2.475. The price has declined in 4 of the last 10 days, resulting in a total change of -20.67% during this period. On the last day, trading volume increase by -824.45K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.57M  shares were traded, amounting to approximately 6.19M.

AQST Technical Signals

AQST(Aquestive Therapeutics Inc Corp) has 3 buy signals and 3 sell signals now. The current trend is consolidation starting from 2025-05-12. The total price change during this trend is -10.70%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of AQST over the last 5 trading days is 7.79M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.

AQST Moving Average Analysis

Aquestive Therapeutics Inc's overall moving average trend leans more bearish as of Saturday, May 17, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $3.187288666666667, and $3.5421666666666667. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.039044666666667, and $1.684166666666667. A break-down below any of these levels will issue sell signals.

AQST Short Selling Analysis

The short sale ratio of Aquestive Therapeutics Inc(AQST) as of 12 May 2025 is 17.07%, rising from last trading day. With increasing price from 2.79 to 2.85. The short sell activity indicate that short sellers may be anticipating a price reversion.

Technical Signal

Technical Signals Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
3

Moving Average

Swing

down ImageNegative

Stock Price Below SMA_5

Short Term

down ImageNegative

SMA_5 Below SMA_20

Mid Term

down ImageNegative

SMA_20 Below SMA_60

Long Term

down ImageNegative

SMA_60 Below SMA_200

Short Selling

Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Commodity Channel Index (20 days, 0.015 constant)

CCI_20_0.015 < -100

-108.365

Bullish

Stochastic RSI %K (14, 14, 3, 3)

STOCHRSIk_14_14_3_3 < 20

15.529

Bullish

Moving Average

Price crosses above 5-day SMA

--

Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 < 0

-0.171

Bearish

Momentum (10 days)

MOM_10 < 0

-0.455

Bearish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 < 0

-0.0739

Bearish

AQST Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Aquestive Therapeutics Inc(AQST), our algorithm predicts AQST's 1-month price at $3.03, with an 8.7%upwardshift. Using a similarity score up to 93.94%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Aquestive Therapeutics Inc (AQST.O) stock, as of Sunday, May 11, 2025 , forecasts a 8.7% change over the next month, based on its high correlation with IRON.O stock patterns. The similarity between their price movements over the analyzed periods is 93.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
stocks logo

AQST

No Data
stocks logo

IRON

Up: 8.7%Similarity: 93.94%

Name

Similarity

Up/Down

stocks logo

IRON.O

93.94%

+8.70%

stocks logo

SUNS.O

93.88%

+3.98%

stocks logo

SIMO.O

93.28%

+14.22%

stocks logo

TENX.O

92.95%

-10.11%

stocks logo

BCTX.O

92.93%

+24.94%

stocks logo

ATXS.O

92.91%

-6.38%

stocks logo

ARWR.O

92.87%

-1.60%

stocks logo

SWKH.O

92.85%

-1.28%

stocks logo

ENIC.N

92.77%

-11.32%

stocks logo

ESRT.N

92.67%

+0.41%

AQST Seasonality Analysis

Based on AQST's historical stock price data across all years, the probability of a positive return in May is28.57%, suggesting it maynotbe an ideal month to invest in AQST. In contrast,Augustoffers the highest probability of positive returns at83.33%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Aquestive Therapeutics Inc (AQST.O) stock in August has the highest probability of a positive return (83.33%), while December has the lowest probability (0.00%).

Performance Seasonality

The chart shows Aquestive Therapeutics Inc. (AQST)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.

People Also Watch

FAQ

arrow icon

Should I buy Aquestive Therapeutics Inc (AQST.O) stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. AQST has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
arrow icon

Which months have the highest win rate for buying Aquestive Therapeutics Inc (AQST.O) stock in a year?

The radar chart shows that buying Aquestive Therapeutics Inc (AQST.O) stock in August has the highest probability of a positive return (83.33%), while December has the lowest probability (0.00%).

arrow icon

How has Aquestive Therapeutics Inc. (AQST)'s stock price performed over the past three years?

AQST's stock price rose by 124.44% in 2023,increased by 77.11% in 2024, and went down by 35.15% in 2025.

arrow icon

Which bull technical signals does AQST have?

Bullish technical signals of AQST include: CCI_20_0.015 < -100, STOCHRSIk_14_14_3_3 < 20, Price crosses above 5-day SMA.

arrow icon

Which bearish technical signals does AQST have?

Bearish technical signals of AQST include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0.

arrow icon

Is AQST a buy based on overall technical signals summary?

AQST has 3 buy signals and 3 sell signals now. Overall the technical rating for AQST is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of AQST.

arrow icon

What is the trend of Aquestive Therapeutics Inc (AQST)'s moving average?

Aquestive Therapeutics Inc's overall moving average trend leans more bearish as of May 17 2025, with 4 negative signals and 0 positive signal.

arrow icon

What is price prediction for AQST stock next month?

The price prediction chart for Aquestive Therapeutics Inc (AQST.O) stock, as of May 11 2025, forecasts a 8.7% change over the next month, based on its high correlation with IRON stock patterns. The similarity between their price movements over the analyzed periods is 93.94%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

arrow icon

What is price prediction 2025 for AQST Stock?

Aquestive Therapeutics (AQST) stock is predicted to trade between **$1.80 and $4.20** by Q4 2025. - **Bullish Scenario**: The stock could rise to **$4.20** if Anaphylm gains FDA approval and shows strong pre-launch momentum. - **Bearish Scenario**: The stock may drop to **$1.80** if regulatory delays occur or revenue guidance is missed. The prediction is based on the company's Q4 financial performance and upcoming FDA review of Anaphylm.

arrow icon

What is price prediction 2030 for AQST Stock?

### **Price Prediction for AQST Stock by 2030** - **$15**: Conservative estimate, assuming moderate growth and successful commercialization of Anaphylm with limited market penetration. - **$25**: Bullish scenario, driven by strong demand for Anaphylm and expansion into new markets. - **$5**: Bearish case, if the company faces significant regulatory or commercialization challenges. **Reasons**: - **Anaphylm Launch**: Positive pediatric trial results and upcoming FDA review in Q2 2025 position AQST for potential market expansion. - **Valuation**: Current low stock price with upside potential if products gain traction. - **Pipeline Strength**: Strong development pipeline beyond Anaphylm supports long-term growth.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free